Left ventricular diastolic function during adrenergic stress in essential hypertension: Acute and chronic effects of ACE inhibition

Cardiovascular Drugs and Therapy

Volumn 10, Issue 3, 1996, Pages 321-329

  Covi, Grazia ^a,c   Sheiban, Imad ^d   Gelmini, Giampaolo ^a   Arcaro, Guido ^a   Tonni, Silvia ^a   Bolner, Andrea ^b   Piemonte, Giuseppe ^b   Lechi, Alessandro ^a  

^a Clinica Medica   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d NONE

Author keywords

ACE inhibition; Angiotensin II; Diastolic function; Essential hypertension

Indexed keywords

CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ADRENERGIC STIMULATION; ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COLD PRESSOR TEST; DIASTOLE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART AFTERLOAD; HEART ATRIUM CONTRACTION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE RELAXATION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; LISINOPRIL; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0029763910     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tuck ML. The sympathetic nervous system in essential hypertension. Am Heart J 1986;112:877-887.
2. Johnston CI. Renin-angiotensin system: A dual tissue and hormonal system for cardiovascular control. J Hypertens 1992;10(Suppl 7):S13-S26.
3. Re R. The myocardial intracellular renin-angiotensin system. Am J Cardiol 1987;59:56A-58A.
4. Dzau VJ. Cardiac renin-angiotensin system: Molecular and functional aspects. Am J Med 1988;84(Suppl 3A):22-27.
5. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69: 475-482.
6. Schunkert H, Jackson B, Tang SS, et al. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat heart. Circulation 1993;87: 1328-1339.
7. Jin M, Wilhelm MJ, Lang RE, Unger T, Lindpainter K, Ganten D. Endogenous tissue renin-angiotensin system: From molecular biology to therapy. Am J Med 1988; 84(Suppl 3A):28-36.
8. Mebazzaa A, Chevalier B, Mercadier JJ, Echter E, Rapaport L, Swinghedauw B. A review of the renin-angiotensin system in the normal heart. J Cardiovasc Pharmacol 1989; 14(Suppl 4):S16-S20.
9. Grinstead WC, Young JB. The myocardial renin-angiotensin system: Existence, importance, and clinical implications. Am Heart J 1992;123:1039-1045.
10. Hartford M, Wikstrand J, Wallentin I, Ljungman S, Wilhelmsen L, Berglund G. Diastolic function of the heart in untreated primary hypertension. Hypertension 1984;6: 329-338.
11. Papademetriou V, Gottdiener JS, Fletcher RD, Freis ED. Echocardiographic assessment by computer-assisted analysis of diastolic left ventricular function and hypertrophy in borderline or mild systemic hypertension. Am J Cardiol 1985;56:546-550.
12. Sheiban I, Arcaro G, Covi G, Accardi R, Zenorini C, Lechi A. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril. J Cardiovasc Pharmacol 1987;10(Suppl 10):s187-s191.
13. Inouye I, Massie B, Loge D. Abnormal left ventricular filling: An early finding in mild systemic hypertension. Am J Cardiol 1984;53:120-126.
14. Sheiban I, Covi G, Zenorini C, et al. Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine. Cardiovasc Drugs Ther 1990;4: 957-962.
15. Khairallah PA: Action of angiotensin on adrenergic nerve endings. Fed Proc 1972, 31:1351-1357.
16. Xiang JZ, Schoelkens BA, Ganten D, Unger T. Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe-498 in isolated rabbit hearts. Clin Exp Hypertens 1984;6:1853-1857.
17. Eberli FR, Apstein CS, Ngoy S, Lorell BH. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme. Circ Res 1992;70:931-943.
18. Haber HL, Powers ER, Gimple LW et al. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 1994;89:2616-2625.
19. Piemonte G, Bolner A, Moghetti P, et al. Measurement of plasma catecholamines. Study at basal and during insulin-induced hypoglycemia in normal and diabetic subjects. In Piemonte G, Tagliaro F, Marigo M, Frigerio F, eds. Developments in Analytical Methods in Pharmaceutical, Biomedical and Forensic Sciences. New York: Plenum Press, 1987:257-270.
20. Covi G, Sheiban I, Gelmini GP, et al. Left ventricular diastolic function and responses to adrenergic stimuli in borderline arterial hypertension. J Hypertens 1992;10:237-243.
21. Frohlich ED, Iwata T, Sasaki O. Clinical and physiologic significance of local tissue renin-angiotensin systems. Am J Med 1989;87(Suppl 6B):6S-19S.
22. Fowler NO, Holmes JC. Coronary and myocardial actions of angiotensin, Circ Res 1964;14:191-201.
23. Ziogas J, Story DF, Rand MJ. Effects of locally generated AII on noradrenergic transmission in guinea pig isolated atria. Eur J Pharmacol 1985:106;11-18.
24. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy? J Hypertension 1991;9:3-15.
25. Khairallah PA, Robertson AL, Davila D. Effects of angiotensin II on DNA, RNA and protein synthesis. In Genest J, Koiw R, eds. Hypertension. New York: Springer Verlag, 1972:212-220.
26. Clements JP, Bailey KR, Zacharia PK. Effects of exercise and therapy on ventricular emptying and filling in mildly hypertensive patients. Am J Hypertens 1994;7:695-702.
27. Gambelli G, Amici E, Selvanetti A. Effects of nifedipine on left ventricular diastolic function in hypertension: Echo Doppler study. Cardiovasc Drugs Ther 1990;4:951-955.
28. Brutsaert D, Rademaker F, Sys SU. Triple control of relaxation: Implications in cardiac disease. Circulation 1984;69: 190-196.
29. Timio M, Venanzi S, Gentili S, Ronconi M, Del Re G, DeVita M. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: Relationship between echocardiographic findings, blood pressure, and urinary catecholamines. J Cardiovasc Pharmacol 1987;10:142-146.
30. Ibrahim MM, Zaghloul SS, Helmi SM. Effect of regression of left ventricular hypertrophy following sotalol therapy on diastolic function in hypertensive patients. J Hypertens 1987;5(Suppl):S411-S414.
31. Haberbosch W, DeSimone R, Dietz R, Waas W, Tillmanns H, Kubler W. Improvement of diastolic filling in hypertensive patients treated with cilazapril. J Cardiovasc Pharmacol 1991;17(Suppl 2):S159-S162.
32. Grandi M, Venco A, Barizza F, Casadei B, Marchesi E, Finardi G. Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 1989; 63:1093-1096.
33. Allen IS, Cohen NM, Dhallen RS, Gaa ST, Lederer WJ, Rogers TB. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: Insights into the underlying mechanisms. Circ Res 1988;62:524-534.